0001171623-13-000001.txt : 20130621
0001171623-13-000001.hdr.sgml : 20130621
20130621162529
ACCESSION NUMBER: 0001171623-13-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20130621
DATE AS OF CHANGE: 20130621
EFFECTIVENESS DATE: 20130621
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DIFFUSION PHARMACEUTICALS LLC
CENTRAL INDEX KEY: 0001171623
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-198432
FILM NUMBER: 13927377
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT, #4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 434-220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT, #4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
D
1
primary_doc.xml
X0706
D
LIVE
0001171623
DIFFUSION PHARMACEUTICALS LLC
2020 AVON COURT, #4
CHARLOTTESVILLE
VA
VIRGINIA
22902
434-220-0718
VIRGINIA
None
None
Limited Liability Company
true
David
G.
Kalergis
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Director
John
L.
Gainer
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Director
Thomas
E.
Byrne
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Director
Robert
W.
Adams
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Director
Mark
T.
GIles
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Director
Ben
L.
Shealy
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Kim
Whitten
2020 AVON COURT, #4
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06
false
2013-05-30
false
true
true
true
true
Each convertible note bears interest of 1.0% for four years and is convertible into membership units of the Company at a conversion price of $1.25 per unit.
false
0
5000700
5000700
0
false
19
0
0
0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
false
DIFFUSION PHARMACEUTICALS LLC
/s/ Ben L. Shealy
Ben L. Shealy
Chief Financial Officer and Treasurer
2013-06-20